ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0576

Less Than 15% Unfavourable Pregnancy Outcomes in Patients with Recent-onset Axial Spondyloarthritis: The Analysis of the 10 Years DESIR Cohort Follow-up

Madeleine FRANC1, Anne Tournadre2 and Anna Molto3, 1Groupe Hospitalier Cochin, APHP, Paris, France, 2Service de Rhumatologie, centre hospitalier universitaire de Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France, 3Groupe Hospitalier Cochin, AP-HP, Paris, France

Meeting: ACR Convergence 2024

Keywords: pregnancy, spondyloarthritis, Women's health

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 16, 2024

Title: SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Only scarce data is available regarding pregnancy outcomes in early axSpA. The objective of this study was to determine (a) the factors associated with the occurrence of a clinical pregnancy during follow-up and (b) the risk factors for an unfavourable pregnancy outcome (e.g. miscarriage, medical termination or pre-term delivery) in an early axSpA population after 10 years of follow up.

Methods: Observational prospective French cohort (DESIR) with 10 years of follow-up including 381 TNFi-naïve women of reproductive age, with axSpA with less than 3 y.  Study visits were scheduled every 6 months in the first two years and then yearly for up to 10 years. Data on pregnancy were collected retrospectively (before cohort inclusion) and prospectively (since inclusion) up to 10y of follow-up. Baseline characteristics were compared between nulligravidae and uni/multigravidae patients. The probability of achieving at least one pregnancy over time was estimated (Kaplan Meier). Factors associated with a clinical pregnancy occurring over follow-up and risk factors for an unfavourable pregnancy outcome (e.g. miscarriage, medical termination or pre-term delivery) were estimated by shared fraility models.

Results: Overall 724 pregnancies in 381 women occurred, before and after inclusion. After 10 years, 294 (77.1%) patients had at least one pregnancy and 96 (22.8%) had none. Multigravidae women were significantly older (37±8 vs 28 ± 7, p< 0.001) and had higher BASFI (3.5±2.4 vs 2.8±2.2, p=0.008) scores at baseline. The mean age of first pregnancy was 26.1 ±5.4 years old. One hundred and fifty three pregnancies occurred during follow up. Except for age, no factor was found to be associated with pregnancy over follow-up. Among the 107 pregnancies prospectively collected with data available on the outcome, 87 (81.3%) presented a full-term delivery, while 16 (14.9%) presented an unfavourable pregnancy outcome (8 (7.5%) and 6 (5.6%) had a miscarriage or a pre-term delivery, respectively, 2 (1.9%) had a medical abortion), 3 (2.8%) had an elective abortion, and 1 (0.9%) were pregnancies still ongoing at the end of follow-up. The probability of presenting an unfavorable outcome over the 10 years of follow up was 13% [0.1-0.2]. No factor was found to be associated with unfavourable pregnancy outcome (Table1).

Characteristic in the 6 months prior to pregnancy,

 Favourable outcome   
N= 93

Unfavourable outcome     
 N = 16

p-value

 mean (sd) or n (p)

Age, years

32.3 (4.8)

33.1 (4.2)

0.7

BMI, kg/m2

25.2 (4.4)

26.5 (5.3)

0.4

Tabac

9 (10%)

1 (6.3%)

>0.9

BASDAI, (0-100)

37 (21)

45 (20)

0.13

ASDAS CRP

2.26 (0.95)

2.52 (0.73)

0.2

CRP ≥ 6 mg/L

63 (75%)

12 (86%)

0.5

Arthritis

33 (36%)

7 (44%)

0.6

CsDMARD use

2 (2.3%)

1 (6.3%)

0.4

Orale corticosteroids use

8 (12%)

2 (17%)

0.6

NSAID use

53 (58%)

11 (69%)

0.4

Anti TNF alpha use

17 (20%)

6 (38%)

0.2

Table 1 : Characteristics of patients in the 6 months prior to favourable outcome pregnancies vs. unfavourable outcome pregnancies

Conclusion: After 10 years of follow-up of 381 women with recent-onset axSpa, more than 75% had at least one pregnancy. Of all pregnancies that occurred during follow up, an unfavourable outcome was observed in less than 15% of them.


Disclosures: M. FRANC: None; A. Tournadre: None; A. Molto: AbbVie, 2, 5, MSD, 2, 5, Pfizer, 2, 5, UCB, 2, 5.

To cite this abstract in AMA style:

FRANC M, Tournadre A, Molto A. Less Than 15% Unfavourable Pregnancy Outcomes in Patients with Recent-onset Axial Spondyloarthritis: The Analysis of the 10 Years DESIR Cohort Follow-up [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/less-than-15-unfavourable-pregnancy-outcomes-in-patients-with-recent-onset-axial-spondyloarthritis-the-analysis-of-the-10-years-desir-cohort-follow-up/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/less-than-15-unfavourable-pregnancy-outcomes-in-patients-with-recent-onset-axial-spondyloarthritis-the-analysis-of-the-10-years-desir-cohort-follow-up/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology